Sign in

CIK 0001831915 · Accelerated filer

Cytek Biosciences, Inc.

Sign in to watch
Ticker
CTKB
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472547526
Phone
(877) 922-9835
Business address
47215 LAKEVIEW BOULEVARD, FREMONT, CA, 94538
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy Director bought 441,865 shares at an average $12.95 ($5,721,951)
  5. 4 Open-market buy Director bought 420,380 shares at an average $13.23 ($5,559,664)
  6. 4 Open-market sale Chief Technology Officer sold 20,000 shares at $13.44 ($268,800)
  7. 4 Open-market buy Director bought 547,380 shares at an average $14.06 ($7,695,707)
  8. 4 Open-market buy Director bought 498,629 shares at an average $14.89 ($7,426,825)
  9. 4 Open-market sale Chief Technology Officer sold 20,000 shares at an average $15.11 ($302,106)
  10. 5 Insider Annual Insider Trading Report
  11. 4 Open-market sale President and CEO sold 20,000 shares at $14.40 ($288,000)
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy Director bought 2,950,000 shares at $17.00 ($50,150,000)
  15. 4 Open-market buy General Counsel bought 1,900 shares at $17.00 ($32,300)
  16. 4 Open-market buy Director bought 3,000 shares at $17.00 ($51,000)
  17. 4 Open-market buy Director bought 5,000 shares at $17.00 ($85,000)
  18. 4 Open-market buy SVP Marketing and Corp. Dev. bought 1,500 shares at $17.00 ($25,500)
  19. 4 Conversion Director acquired 4,760,510 shares (conversion)
  20. 4 Conversion President and CEO acquired 2,666,600 shares (conversion)

Page 14 of 15 · 295 filings